FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890670713> ?p ?o ?g. }

• W2890670713 abstract "Introduction Hypertension is a common comorbidity affecting patients with left ventricular assist devices (LVAD). Left uncontrolled, it may lead to a decrease in LVAD support and increase the risk for stroke. The ISHLT defines hypertension in LVAD patients as a mean arterial pressure (MAP) of > 90 mmHg and recommends aggressive management utilizing standard heart failure medications. Sacubitril-valsartan (Entresto®) is an angiotension II blocker-neprilysin inhibitor with potent anti-hypertensive effects approved for the treatment of heart failure with a reduced ejection fraction. Our aim was to assess blood pressure control with sacubitril-valsartan versus standard anti-hypertensive therapy in our LVAD patients. Methods This is a single center evaluation of MAP reduction, stroke and readmission rates associated with sacubitril-valsartan versus standard anti-hypertensives in our HeartMate II (HMII) LVAD patients with a diagnosis of hypertension. Initial MAP measured by Doppler was assessed prior to initiation or intensification of therapy post LVAD implant and compared to the most recent clinic visit MAP. Patients were excluded if they did not have a recent MAP, were on intravenous inotropic therapy, were non-compliant or were implanted with an LVAD other than HMII. Results Due to exclusion criteria, only 26 patients were assessed, with 12 treated with sacubitril-valsartan. Patients treated with sacubitril-valsartan had an average MAP reduction of 20 mmHg. Those on standard anti-hypertensives had an average MAP reduction of 12 mmHg. Of the patients in the standard group, 46% had a documented stroke whereas no patients in the sacubitril-valsartan group had a stroke. Readmissions were also lower in the sacubitril-valsartan group with these patients requiring an average of three fewer hospitalizations. Adverse effects associated with sacubitril-valsartan were reported in three patients and included hypovolemia and lightheadedness leading to two discontinuations. Discussion In this single center retrospective analysis of HMII LVAD patients, sacubitril-valsartan provided a larger reduction in MAP when compared to standard anti-hypertensive therapy. Patients in the sacubitril-valsartan group were less likely to have a stroke and required fewer readmissions than those on standard therapies. Due to the non-randomized, retrospective nature of this study, confounding factors cannot be ruled out. Randomized trials are ongoing to assess the clinical benefits of its use on a larger scale." @default.
• W2890670713 created "2018-09-27" @default.
• W2890670713 creator A5017778924 @default.
• W2890670713 creator A5020882802 @default.
• W2890670713 creator A5046965094 @default.
• W2890670713 creator A5048707311 @default.
• W2890670713 creator A5048981513 @default.
• W2890670713 creator A5056577964 @default.
• W2890670713 creator A5070767696 @default.
• W2890670713 creator A5088566010 @default.
• W2890670713 creator A5091155398 @default.
• W2890670713 date "2018-08-01" @default.
• W2890670713 modified "2023-09-23" @default.
• W2890670713 title "Sacubitril-Valsartan versus Standard Anti-Hypertensives in Left Ventricular Assist Device Patients" @default.
• W2890670713 doi "https://doi.org/10.1016/j.cardfail.2018.07.086" @default.
• W2890670713 hasPublicationYear "2018" @default.
• W2890670713 type Work @default.
• W2890670713 sameAs 2890670713 @default.
• W2890670713 citedByCount "1" @default.
• W2890670713 countsByYear W28906707132020 @default.
• W2890670713 crossrefType "journal-article" @default.
• W2890670713 hasAuthorship W2890670713A5017778924 @default.
• W2890670713 hasAuthorship W2890670713A5020882802 @default.
• W2890670713 hasAuthorship W2890670713A5046965094 @default.
• W2890670713 hasAuthorship W2890670713A5048707311 @default.
• W2890670713 hasAuthorship W2890670713A5048981513 @default.
• W2890670713 hasAuthorship W2890670713A5056577964 @default.
• W2890670713 hasAuthorship W2890670713A5070767696 @default.
• W2890670713 hasAuthorship W2890670713A5088566010 @default.
• W2890670713 hasAuthorship W2890670713A5091155398 @default.
• W2890670713 hasConcept C126322002 @default.
• W2890670713 hasConcept C127413603 @default.
• W2890670713 hasConcept C164705383 @default.
• W2890670713 hasConcept C2775999527 @default.
• W2890670713 hasConcept C2776754050 @default.
• W2890670713 hasConcept C2777387769 @default.
• W2890670713 hasConcept C2778198053 @default.
• W2890670713 hasConcept C2778774980 @default.
• W2890670713 hasConcept C2780645631 @default.
• W2890670713 hasConcept C71924100 @default.
• W2890670713 hasConcept C78085059 @default.
• W2890670713 hasConcept C78519656 @default.
• W2890670713 hasConcept C84393581 @default.
• W2890670713 hasConceptScore W2890670713C126322002 @default.
• W2890670713 hasConceptScore W2890670713C127413603 @default.
• W2890670713 hasConceptScore W2890670713C164705383 @default.
• W2890670713 hasConceptScore W2890670713C2775999527 @default.
• W2890670713 hasConceptScore W2890670713C2776754050 @default.
• W2890670713 hasConceptScore W2890670713C2777387769 @default.
• W2890670713 hasConceptScore W2890670713C2778198053 @default.
• W2890670713 hasConceptScore W2890670713C2778774980 @default.
• W2890670713 hasConceptScore W2890670713C2780645631 @default.
• W2890670713 hasConceptScore W2890670713C71924100 @default.
• W2890670713 hasConceptScore W2890670713C78085059 @default.
• W2890670713 hasConceptScore W2890670713C78519656 @default.
• W2890670713 hasConceptScore W2890670713C84393581 @default.
• W2890670713 hasLocation W28906707131 @default.
• W2890670713 hasOpenAccess W2890670713 @default.
• W2890670713 hasPrimaryLocation W28906707131 @default.
• W2890670713 hasRelatedWork W2749965599 @default.
• W2890670713 hasRelatedWork W2919008909 @default.
• W2890670713 hasRelatedWork W2923219557 @default.
• W2890670713 hasRelatedWork W2987185485 @default.
• W2890670713 hasRelatedWork W3025281820 @default.
• W2890670713 hasRelatedWork W3029174432 @default.
• W2890670713 hasRelatedWork W3137017377 @default.
• W2890670713 hasRelatedWork W4200158067 @default.
• W2890670713 hasRelatedWork W4210909263 @default.
• W2890670713 hasRelatedWork W4213070686 @default.
• W2890670713 isParatext "false" @default.
• W2890670713 isRetracted "false" @default.
• W2890670713 magId "2890670713" @default.
• W2890670713 workType "article" @default.